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Introduction: Verrucous carcinoma of the external genitalia and perianal region is a rare variant of well-differentiated
squamous cell carcinoma. It has been reported to have limited metastatic potential.
Case presentation: We report the case of a 54 year-old Moroccan man who presented with locally advanced giant
condyloma acuminatum (Buschke–Löwenstein tumor) after prolonged intervals of neglect (approximately 10 years). The
disease covered his suprapubic, external genitalia and perianal region. It was locally aggressive with extensive tissue
destruction. After a biopsy of the lesion, the diagnosis of verrucous carcinoma was confirmed. He initially received
chemoradiotherapy, followed by extensive local excision, but he developed septic shock and died a few days later.
Conclusions: The purpose of this case report is to present a case of verrucous carcinoma arising in an extensive giant
condyloma acuminatum (Buschke–Löwenstein tumor) and discuss the literature on its diagnosis and management.
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Verrucous carcinomaIntroduction
Verrucous carcinoma (VC) was first described as a dis-
tinct well-differentiated variety of squamous cell carcin-
oma (SCC) by Ackerman [1]. VC tends to appear mainly
in oropharynx, genitalia and soles of the feet, although it
may occur anywhere on the skin. Thus, VC has been
known by several different names in relation to the ana-
tomical site of the lesion. Different treatment modalities are
described for patients with VC [2,3]. Buschke–Löwenstein
tumor (BLT), or giant condyloma acuminatum (GCA), was
first described by Buschke and Löwenstein in 1925 [4]. It is
a rare sexually transmitted disease; the incidence is esti-
mated to be 0.1% in the general population. It is character-
ized by invasive growth and recurrence after treatment, and
malignant transformation is possible. VC resembles BLT in
clinical appearance and histology. BLT is generally consid-
ered to be VC in genital regions, although there is still some* Correspondence: drahsaini@gmail.com
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reproduction in any medium, provided the orconfusion between BLTand VC; in some reports the lesions
are regarded as distinct entities [5,6]. Moreover, the human
papillomavirus (HPV) positivity rate in VC is lower than in
common GCA [7,8]. To date, these questions remain un-
solved, and several investigators have attempted to eluci-
date the etiology.
To the best of our knowledge, this is the first case re-
port in which a history of BLT is complicated by malig-
nant transformation covering a large part of the patient’s
lower body. We present a recent systematic literature re-
view regarding the clinical presentation and treatment of
this rare tumor.Case presentation
A 54-year-old heterosexual married Moroccan man pre-
sented with a previous uncomplicated medical history. He
did not report any risk factors for human immunodefi-
ciency virus infection (HIV). He was seen in our emergency
department with a foul smelling, exquisitely tender mass
arising in his suprapubic, external genitalia and perianalLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 An extensive erosive, cauliflower-like growth involving
a large part of the lower body.
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lesion had been present for 10 years and had grown slowly
over time. It had been increasing in size over the previous
8 months causing pain and bleeding. His delay was due
to a hospital and needle phobia. A clinical examination
revealed an extensive erosive, cauliflower-like growth
involving a large part of his lower body (42 × 31cm in
diameter; Figure 2). No inguinal or supraclavicular lymph-
adenopathy was detected clinically. He was admitted to the
emergency room where multiple abscesses were drained
and deep biopsies were taken from his tumor. The histo-
logical examination revealed a verrucous architecture with
papillomatosis, acanthosis and a minimal loss of epithelial
cell polarity (Figures 3 and 4). This confirmed the diagnosis
of VC.
Additional radiological investigations consisted of a
thoracic-abdominal-pelvic computed tomography scan
(Figures 5 and 6) which showed the localization of this
tumor in the external genitalia, perineal and suprapubic
region without any lymph nodes or distant metastases.
The results of biochemical and serological investigations
including a HIV test were normal. After discussion among
the oncologist, radiotherapist, pathologist and surgeon,
the patient was advised to undergo chemoradiation ini-
tially with the aim to reduce the size of his tumor followed
by surgery.
After treatment of a local infection, our patient received
two cycles of intravenous chemotherapy given three weekly
with cisplatin 80mg/m2 on day one and 5-fluorouracil (5-
FU) 600mg/m2 on day one to five given as a continuous
infusion. After two cycles of chemotherapy the tumor size
was reduced to 30% of initial size. The radiation was
planned in two phases, two total doses of 45Gy in 25 frac-
tions over 5 weeks, given at 1.8Gy per fraction. The com-
bined therapy was well tolerated with just diarrhea as a
side effect. Six months after completing the treatment, heFigure 1 The tumor arising from the suprapubic, external
genitalia and perianal region extended laterally to both thighs.underwent local excision with extensive abdominoperineal
rectum excision and emasculation. In addition, a tempor-
ary diverting colostomy and a bilateral ureterostomy were
constructed. Pedicled anterolateral thigh flaps and abdom-
inal flap were used to cover the perineal defects. Unfortu-
nately he developed septic shock and died some days later.
The final pathology report after surgical resection of the
tissue confirmed the diagnosis of VC.
Discussion
BLT is a rare sexually transmitted disease triggered by
HPV, usually genotype 6 or 11 [4]. Risk factors for HPV
transmission are: multiple sexual partners, prostitution,
homosexuality, lack of hygiene, and chronic genital infec-
tions. BLT is always preceded by condyloma acuminatum
and the immune system is probably suppressed. It can be
associated with congenital or acquired immunodeficiency,Figure 3 Verrucous architecture with papillomatosis, acanthosis
and minimal loss of epithelial cell polarity (hematoxylin and
eosin staining × 5).
Figure 4 Koilocytosis and cellular binucleation (hematoxylin
and eosin staining × 10).
Figure 6 Computed tomography of the abdominal-pelvic floor
showing the tumor invading the suprapubic region (white arrow).
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pressive therapy [9]. Our patient did not have any of these
risk factors. Other oncogenic subtypes, particularly HPV
16, 18, 31, and 33, have a well-known association with
anogenital SCC [10]. Moreover, it is believed that malig-
nant transformation could also be caused by the release of
free oxygen radicals by activated inflammatory cells, indu-
cing genetic damage and neoplastic transformation [11,12].
The absence of high-risk HPV subtypes in a case of
BLT cannot exclude focally invasive SCC. Histopatho-
logical criteria for malignancy and clinical presentation
continue to lead management decisions [5,6]. The aver-
age time for malignant transformation is known to beFigure 5 Computed tomography of the perineum showing the
tumor spreading into the perineum and base of the scrotum
(white arrows).approximately 5 years [12]. Our patient had the tumor
for approximately 10 years. The mean age of patients
with BLT is 43 years, with a male to female ratio of 2:2.
The risk of recurrence after excision is 60 to 66%, with
an overall mortality of 20 to 30%. Malignant transform-
ation has been reported in 30 to 56% of cases [12-14].
The disease is located on the penis in 81 to 94% of
cases, in the anorectal area in 10 to 17%, and in the ur-
ethra in 5%. In females, the location is chiefly the vulva
(90%) and an anorectal location is less frequent [15].
Suprapubic localization is rarely reported in the litera-
ture [16]. Our patient presented with an extensive lesion
involving his suprapubic, external genitalia and perianal
region that extended laterally to both thighs which is
rarely reported in the literature.
Clinically, the tumor presents as exophytic fungating
masses, sometimes with a cauliflower-like morphology.
The gross appearance is generally a bulky tumor sug-
gesting an aggressive behavior, whereas histopathology
reveals a relatively low-grade malignancy. Biologically, this
tumor shows a high recurrence rate and it is characterized
by a low incidence of metastasis [17,18]. Malignant trans-
formation may be suspected when bleeding, pain, and a
rapid increase in tumor size [19] appears. Our patient had
these complications in the last 8 months suggesting the ma-
lignant transformation was probably due to the time delay.
The diagnosis of VC requires evaluation of the clinical
and microscopic appearance and biologic behavior of the
neoplasm [20]. It is important to perform deep skin biop-
sies when clinical suggestion of VC exists.
VC presents as a distinct entity with an exo-endophytic
growth pattern (in contrast to condyloma accuminata) of
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(in contrast to the invasive character of well-differentiated
squamous carcinoma). This results in slow-growing le-
sions, locally invasive behavior, and very infrequent meta-
static spread [11].
Differentiation between BLT and VC is difficult. Some
authors consider these lesions to be similar. However,
others maintain that BLT represents an intermediate le-
sion between condyloma acuminatum and VC, referring
to it as a condyloma-like precancerous lesion [9].
Wide surgical excision, chemoradiation, topical and
intralesional chemotherapy, carbon dioxide laser therapy,
and photodynamic therapy have all been used in different
combinations in the treatment of BLT, with varying suc-
cess. Surgery is the treatment of choice and is effective in
the early stages of the disease. Excision must be wide, and
ranges from the Mohs technique when the size of the
tumor is small, to abdominoperineal excision with pelvic
lymph node dissection if lymph metastasis was suspected
[14,21].
Radiotherapy alone is rarely used; it is usually used
alone when excision cannot be performed or in recur-
rences. It may also be indicated to complement surgery in
the case of an incomplete excision [14,21]. In addition,
radiotherapy is controversial because of the potential for
malignant transformation into aplastic carcinoma and me-
tastasis [22].
Chemotherapy consists of a combination of cisplatin
and 5-FU. The choice of this protocol was based on our
own experience in treatment of patients with anal can-
cer. This combination has been used combined with ra-
diation with acceptable toxicity and positives responses
[23]. In patients with BLT with suspicion of malignant
transformation, the optimal treatment is not well de-
fined. Some authors recommend preoperative chemora-
diotherapy to downstage extensive tumors, followed by
radical surgery [24]. Tytherleigh et al. [25] reported the
case of a patient with unresectable disease who received
neoadjuvant chemoradiotherapy to downsize a tumor with
subsequent complete surgical excision. In our patient, che-
moradiotherapy allowed us to downsize the tumor (30%);
wide excision of the tumor was made possible. However,
due to this extensive procedure associated with significant
morbidity and mortality, our patient died from septic
shock despite extensive antibiotic treatment.
To avoid the recurrent disease some authors suggest
the administration of an autogenous vaccine after surgical
excision. The lowest reported recurrence rate at 1 year
was less than 5% [26].
Conclusions
VC is a rare, locally aggressive tumor. Surgical complete
excision of VC is advised. Other treatment modalities
such as chemotherapy or radiotherapy could be used toavoid mutilating surgical interventions. Based on our case
and other published reports, chemoradiotherapy should
be considered in patients with malignant transformation
of GCA to downsize the tumor. Decision making in re-
garding to the goals of surgical intervention is complex
and involves palliative excision versus a curative excision
which unfortunately has the potential of significant mor-
bidity and mortality. Wide surgical excision with local flap
reconstruction can significantly improve the quality of life.
A regular follow-up is necessary due to frequent recur-
rences and possible distant metastasis.
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